http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010034641-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
filingDate 1999-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2001-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20010034641-A
titleOfInvention An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition
abstract The present invention provides a weight average molecular weight (Mw) of 700-1400 Daltons, preferably about 1,000 Daltons, a number average molecular weight (Mn) of 400-1400 Daltons and 90% by weight of 10% by weight having a molecular weight of less than 2,700 Daltons The weight average molecular weight is less than 3,200 Daltons and includes hydrogenated dextran purified by a membrane process with a cut-off value of 340-800 Daltons and is used for parenteral treatment of iron-deficient anemia. It relates to an iron-dextran compound used stably together. The compounds are precipitated in the presence of dextran in the presence of dextran after the membrane process to remove high molecular weight dextran from hydrogenated dextran and at least about 2,700 daltons of high molecular weight dextran and the heat treatment and purification. To prepare.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020003344-A
priorityDate 1998-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410637400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447797113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10129897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415807098
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454306093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22959485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105075
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4311764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450980184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451095370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451019927
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164179650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451404211

Total number of triples: 40.